相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- CAS号:
176022-59-6
- 规格:
1mg/2mg/5mg/10mg/25mg
| 规格: | 1mg | 产品价格: | ¥1808.0 |
|---|---|---|---|
| 规格: | 2mg | 产品价格: | ¥2600.0 |
| 规格: | 5mg | 产品价格: | ¥4024.0 |
| 规格: | 10mg | 产品价格: | ¥4944.0 |
| 规格: | 25mg | 产品价格: | ¥6528.0 |
Product Introduction
Bioactivity
| 名称 | Roxifiban acetate |
| 描述 | Roxifiban acetate(DMP 754 acetate) is a potent GP IIb / IIIa antagonist that exhibits antiplatelet aggregation activity via immune mediation and can be used in the study of human thrombocytopenia. |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| 溶解度 | DMSO : 7.86 mg/mL (15.49 mM), Sonication is recommended. |
| 关键字 | 罗昔非班醋酸盐 | Roxifiban Acetate | MK 0853 | GPIIb/IIIa |
| 相关产品 | Gantofiban | Cucurbitacin B | 2-hydroxy Flutamide | Bestatin hydrochloride | Cyclo(-RGDfK) | (R)-Leucic acid | Elsibucol | ADH-503 | Tirofiban hydrochloride monohydrate | K34c hydrochloride | CLT-28643 | Lifitegrast |
| 相关库 | Inhibitor Library | Bioactive Compound Library | Bioactive Compounds Library Max | ReFRAME Related Library | Anti-Cardiovascular Disease Compound Library | Cytoskeletal Signaling Pathway Compound Library | Immunology/Inflammation Compound Library |
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验1试剂 (1) 小鼠腹水 (2) 饱和硫酸铵溶液的配制: 称(NH4)2SO4(AR)400~425克,以50~80℃之蒸馏水500ml溶解,搅拌20分钟,趁热过滤。冷却后以浓氨水(15N NH4OH)调PH至7.4。配制好的饱和硫酸铵,瓶底应有结晶析出。 (3) 0.06M, PH4.8醋酸盐缓冲液配制:) `0 }2 j2 v. ] ^ 贮存液:' ~. o6 \5 o5 W1 [7 h A液:0.06M NaAc:无水NaAc0.49218克,加蒸馏
(5)1.0mol/L, pH9.5碳酸盐缓冲液(CBS) NaHCO3 294g Na2 CO3 1.59g 蒸馏水加至 50ml (6)220.0g/L NaCl 取NaCl 22g用蒸馏水溶解后补加至100ml。 (7)0.2mol/L, ph5.6醋酸盐缓冲液 0.2mol/L醋
.08.2310.09.021.08.3210.08.022.08.4110.07.023.08.5110.06.024.08.6210.05.025.08.7410.04.026.08.9210.03.027.09.1010.02.028.0 (3)0.2mol/L醋酸盐缓冲液(pH3.6~5.6)pH0.2mol/L醋酸(ml)0.2mol/L醋酸钠(ml)3.646.33.73.844.06.04.041.09.04.236.813.24.430.519.54.625.524.54.820
技术资料暂无技术资料 索取技术资料









